Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
Clinical trial NCT01835236 · COMPLETED
Trial details
- NCT number
- NCT01835236
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-03
- Primary completion
- 2018-01-11
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.